Literature DB >> 17827229

Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Lars Linderoth1, Thomas L Andresen, Kent Jørgensen, Robert Madsen, Günther H Peters.   

Abstract

We studied secretory phospholipase A(2) type IIA (sPLA(2)) activity toward phospholipids that are derivatized in the sn-1 position of the glycerol backbone. We explored what type of side group (small versus bulky groups, hydrophobic versus polar groups) can be introduced at the sn-1 position of the glycerol backbone of glycerophospholipids and at the same time be hydrolyzed by sPLA(2). The biophysical characterization revealed that the modified phospholipids can form multilamellar vesicles, and several of the synthesized sn-1 functionalized phospholipids were hydrolyzed by sPLA(2). Molecular dynamics simulations provided detailed insight on an atomic level that can explain the observed sPLA(2) activity toward the different phospholipid analogs. The simulations revealed that, depending on the nature of the side chain located at the sn-1 position, the group may interfere with an incoming water molecule that acts as the nucleophile in the enzymatic reaction. The simulation results are in agreement with the experimentally observed sPLA(2) activity toward the different phospholipid analogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827229      PMCID: PMC2134884          DOI: 10.1529/biophysj.107.110106

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  77 in total

Review 1.  Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins.

Authors:  E Valentin; G Lambeau
Journal:  Biochim Biophys Acta       Date:  2000-10-31

2.  Secreted phospholipase A(2) as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue.

Authors:  Jesper Davidsen; Kent Jørgensen; Thomas L Andresen; Ole G Mouritsen
Journal:  Biochim Biophys Acta       Date:  2003-01-10

3.  Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue.

Authors:  S P White; D L Scott; Z Otwinowski; M H Gelb; P B Sigler
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

4.  Unusual mode of binding of human group IIA secreted phospholipase A2 to anionic interfaces as studied by continuous wave and time domain electron paramagnetic resonance spectroscopy.

Authors:  Stéphane Canaan; Robert Nielsen; Farideh Ghomashchi; Bruce H Robinson; Michael H Gelb
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157

5.  Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99.

Authors:  K Sekar; B Z Yu; J Rogers; J Lutton; X Liu; X Chen; M D Tsai; M K Jain; M Sundaralingam
Journal:  Biochemistry       Date:  1997-03-18       Impact factor: 3.162

6.  On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids.

Authors:  Sofiane Bezzine; James G Bollinger; Alan G Singer; Sarah L Veatch; Sarah L Keller; Michael H Gelb
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

7.  Mechanical aspects of membrane thermodynamics. Estimation of the mechanical properties of lipid membranes close to the chain melting transition from calorimetry.

Authors:  T Heimburg
Journal:  Biochim Biophys Acta       Date:  1998-12-09

8.  Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.

Authors:  P Vadas
Journal:  J Lab Clin Med       Date:  1984-12

9.  Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

Authors:  D L Scott; S P White; J L Browning; J J Rosa; M H Gelb; P B Sigler
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

10.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  9 in total

1.  Metabolic profiling reveals that PNPLA3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cells.

Authors:  Hae-Ki Min; Silvia Sookoian; Carlos J Pirola; Jianfeng Cheng; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

2.  Synthesis of phospholipids on a glyceric acid scaffold: design and preparation of phospholipase A2 specific substrates.

Authors:  Renato Rosseto; Joseph Hajdu
Journal:  Tetrahedron       Date:  2014-05-13       Impact factor: 2.457

Review 3.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

4.  Surface dilution kinetics of phospholipase A(2) catalyzed lipid-bilayer hydrolysis.

Authors:  Jasmeet Singh; Radha Ranganathan
Journal:  J Phys Chem B       Date:  2014-02-11       Impact factor: 2.991

5.  Quercetin modulates activities of Taiwan cobra phospholipase A2 via its effects on membrane structure and membrane-bound mode of phospholipase A2.

Authors:  Yi-Ling Chiou; Shinne-Ren Lin; Wan-Ping Hu; Long-Sen Chang
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

6.  Study of Thermomyces lanuginosa lipase in the presence of tributyrylglycerol and water.

Authors:  S Santini; J M Crowet; A Thomas; M Paquot; M Vandenbol; P Thonart; J P Wathelet; C Blecker; G Lognay; R Brasseur; L Lins; B Charloteaux
Journal:  Biophys J       Date:  2009-06-17       Impact factor: 4.033

Review 7.  Computational Simulations to Guide Enzyme-Mediated Prodrug Activation.

Authors:  Milica Markovic; Shimon Ben-Shabat; Arik Dahan
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

8.  Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs.

Authors:  Milica Markovic; Shimon Ben-Shabat; Shahar Keinan; Aaron Aponick; Ellen M Zimmermann; Arik Dahan
Journal:  Int J Mol Sci       Date:  2019-05-05       Impact factor: 5.923

9.  PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy.

Authors:  Milica Markovic; Shimon Ben-Shabat; Jagadeesh Nagendra Manda; Karina Abramov-Harpaz; Clil Regev; Yifat Miller; Aaron Aponick; Ellen M Zimmermann; Arik Dahan
Journal:  Pharmaceutics       Date:  2022-03-18       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.